Galaxy Digital Inc. Class A (0P0 F) stock market data APIs
€14.9502
-0.1(-0.7%)
as of April 2, 2026
Try our APIs with
free plan!
Galaxy Digital Inc. Class A Financial Data Overview
Price chart is built with
Anychart
Prev. Close
14.9502
Open
14.8502
High
15.1083
Low
14.4377
52 wk Range
7.102-38.8
Market Cap
6 451 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Galaxy Digital Inc. Class A data using free add-ons & libraries
Get Galaxy Digital Inc. Class A Fundamental Data
Galaxy Digital Inc. Class A Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Galaxy Digital Inc. Class A News
New
Alcon's (ALC) Latest Buyout to Enhance Its Product Portfolio
Alcon Inc. ALC recently completed its Aerie Pharmaceuticals, Inc. acquisition, announced in August this year. Following the completion, Alcon intends to integrate Aerie into its business. The transac...
Durham loses public company HQ with Alcon-Aerie deal complete
Former executives at Aerie Pharmaceuticals are in line for major payouts totaling millions of dollars now that the merger with Alcon is complete. Continue reading
Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business
Leveraging Alcon’s robust commercial capabilities and resources to drive further growth and access to Rocklatan and Rhopressa Acquisition adds pharmaceutical research and development capabilities an...
Aerie Pharmaceuticals (AERI) Reports Q3 Loss, Tops Revenue Estimates
Aerie Pharmaceuticals (AERI) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to loss of $0.72 per share a year ago. These figure...
Get Galaxy Digital Inc. Class A fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
